Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis-Reference-Cited by-同舟云学术

Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis

Published:2020-12-31 Issue:4 Volume:35 Page:830-837
ISSN:2093-596X
Container-title:Endocrinology and Metabolism
language:en
Short-container-title:Endocrinol Metab

Author:

Ahn Jonghwa^ORCID,Jin Meihua,Song Eyun,Jeon Min Ji,Kim Tae Yong,Ryu Jin-Sook,Kim Won Bae,Shong Young Kee,Han Ji Min^ORCID,Kim Won Gu^ORCID

Funder

National Research Foundation of Korea

Publisher

Korean Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://e-enm.org/upload/pdf/enm-2020-747.pdf

Reference28 articles.

1. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

2. Impact of delayed radioiodine therapy in intermediate‐/high‐risk papillary thyroid carcinoma

3. Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study

4. Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer

5. Radioactive iodine in differentiated thyroid cancer: a national database perspective

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the selection and timing of postoperative radioiodine treatment in patients with differentiated thyroid carcinoma;Annals of Nuclear Medicine;2024-07-24

2. Analysis of delayed initial radioactive iodine therapy and clinical outcomes in papillary thyroid cancer: a two-center retrospective study;Nuclear Medicine Communications;2024-06-04

3. Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated Thyroid Cancer in the West of Scotland: A Retrospective Analysis;Endocrine Practice;2024-04

4. Radioiodine ablation after thyroidectomy could be safely abandoned or postponed in selected stage I papillary thyroid carcinoma patients of low-risk group: an observational prospective study;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2024-03-03

5. Dynamic risk assessment in patients with differentiated thyroid cancer;Reviews in Endocrine and Metabolic Disorders;2023-11-28